Tech Company Inital Public Offerings
NuPathe IPO
Operating out of Conshohocken, NuPathe completed its IPO.
Transaction Overview
Company Name
Announced On
8/6/2010
Transaction Type
IPO
Amount
$50,000,000
Proceeds Purpose
Proceeds purposes are on file in the company statements with the SEC.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
227 Washington Street 200
Conshohocken, PA 19428
USA
Conshohocken, PA 19428
USA
Phone
Website
Email Address
Overview
NuPathe Inc. is a specialty pharmaceutical company specializing in the acquisition and development of important and innovative therapeutic products in the area of neuroscience.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Armando Anido
Chief Financial Officer
Keith Goldan
Chief Scientific Officer
MarK Pierce
President
Terri Sebree
VP - General Counsel
Michael Marino
VP - Operations
Ezra Felker
Browse more venture capital transactions:
Prev: 8/5/2010: Automated Insights venture capital transaction
Next: 8/6/2010: Syndax Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs